肥胖相关晚期糖基化终末产物在人类子宫腔内对子宫内膜功能和胚胎植入能力的不良影响
研究比较瘦与肥胖女性子宫腔灌洗液中晚期糖基化终末产物(AGEs)水平,并在体外用肥胖水平AGEs处理子宫内膜上皮细胞、基质细胞和滋养层细胞,发现其激活炎症信号、引起内质网应激、损害蜕膜化、削弱囊胚模拟物植入和滋养层侵袭。
要点
- 肥胖女性子宫腔AGEs水平显著高于瘦女性(P=0.004)。
- 肥胖水平AGEs激活子宫内膜上皮细胞p65 NFκB并抑制其黏附和增殖。
- 肥胖水平AGEs损害子宫内膜基质细胞蜕膜化并激活内质网应激。
核心结论
- 肥胖女性子宫腔内升高的AGEs可能不良影响子宫内膜功能、胚胎植入和胎盘发育。
研究设计与样本
- 研究检测瘦女性(BMI 19.5-24.9,n=17)和肥胖女性(BMI>30,n=16)的子宫灌洗液和组织。
- 体外实验使用人子宫内膜上皮细胞系、滋养外胚层球状体、滋养层细胞系和原代人基质细胞。
主要发现
- 肥胖女性子宫腔灌洗液AGEs为6503.59 μmol/mol赖氨酸,显著高于瘦女性的2165.88 μmol/mol赖氨酸(P=0.004)。
- 肥胖女性增殖期子宫内膜组织中AGEs、RAGE和NFκB免疫染色增加。
- 肥胖水平AGEs抑制子宫内膜上皮(ECC-1)细胞黏附和增殖,并抑制滋养外胚层球状体黏附和HTR8/SV-neo滋养层细胞侵袭。
- 肥胖水平AGEs影响原代人子宫内膜基质细胞蜕膜化并激活内质网应激。
临床怎么用
- 作者认为,不孕症检查中评估子宫AGEs可能有助于确定不孕的潜在原因。
- 作者认为,AGEs可被药物靶向,此类治疗可能有效改善肥胖女性的生殖并发症。
局限性
- 机制研究在体外进行,可能不能完全重现体内细胞功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do obese levels of advanced glycation end products (AGEs) within the uterine cavity detrimentally alter tissue function in embryo implantation and placental development? SUMMARY ANSWER: Obese levels of AGEs activate inflammatory signaling (p65 NFκB) within endometrial epithelial cells and alter their function, cause endoplasmic reticulum (ER) stress in endometrial stromal cells and impair decidualization, compromise implantation of blastocyst mimics and inhibit trophoblast invasion. WHAT IS KNOWN ALREADY: Obese women experience a higher incidence of infertility, recurrent miscarriage and pregnancy complications compared with lean women. Oocyte donation cycles suggest a detrimental uterine environment plays a role in these outcomes. STUDY DESIGN, SIZE, DURATION: Uterine lavage and tissues from lean (BMI 19.5-24.9, n = 17) and obese (BMI > 30, n = 16) women examined. Cell culture experiments utilizing human endometrial epithelial, trophectoderm and trophoblast cell lines and primary human stromal cells used to examine the functional impact of obese levels of AGEs. PARTICIPANTS/MATERIALS, SETTING, METHODS: Levels of AGEs examined within uterine lavage assessed by ELISA to determine differences between lean and obese women. Expression and localization of AGEs, receptor for AGEs (RAGE) and NFκB within endometrial tissues obtained from lean and obese women determined by immunohistochemistry. Endometrial epithelial cells (ECC-1), primary human stromal cells and trophoblast cells (HTR8-SVneo) treated with lean (2000 nmol/mol lysine) or obese (8000 nmol/mol lysine) uterine levels of AGEs and p65 NFκB (western immunoblot), real-time adhesion, proliferation migration and invasion (xCelligence real-time cell function analysis), decidualization (cell morphology and prolactin release), ER stress (western immunoblot for p-PERK) determined. Co-cultures of endometrial epithelial cells and blastocyst mimics (trophectoderm spheroids) similarly treated with lean or obese uterine levels of AGEs to determine their impact on embryo implantation. MAIN RESULTS AND THE ROLE OF CHANCE: AGEs were significantly elevated (P = 0.004) within the obese (6503.59 μmol/mol lysine) versus lean (2165.88 μmol/mol lysine) uterine cavity (uterine lavage) with increased immunostaining for AGEs, RAGE and NFkB within obese endometrial tissues during the proliferative phase of the menstrual cycle. Obese uterine levels of AGEs inhibited adhesion and proliferation of endometrial epithelial (ECC-1) cells compared to treatment with lean uterine levels of AGEs. Obese uterine AGE levels impacted primary human endometrial stromal cell decidualization and activated ER stress within these cells. Obese uterine levels of AGEs also inhibited trophectodermal spheroid adhesion to hormonally primed endometrial epithelial cells and trophoblast cell line HTR8/SV-neo invasion. LARGE SCALE DATA: N/A. LIMITATIONS REASONS FOR CAUTION: Mechanistic studies are performed in vitro and may not completely recapitulate cell function in vivo. WIDER IMPLICATIONS OF THE FINDINGS: These data corroborate clinical data suggesting the presence of an altered uterine environment in obese women and demonstrate that elevated uterine levels of AGEs within these women may detrimentally impact endometrial function, embryo implantation and placental development. Uterine AGE assessment in infertility work up may prove useful in determining underlying causes of infertility. AGEs can be targeted pharmacologically and such treatments may prove effective in improving reproductive complications experience by obese women. STUDY FUNDING/COMPETING INTEREST(S): Supported by NHMRC Fellowship (#1002028 to L.A.S.), and the Victorian Government's Operational Infrastructure Support Program. MTC is supported by a JDRF Australia Clinical Research Network Career Development Award. The authors have declared that no conflict of interest exists.
引用
- Antoniotti GS, Coughlan M, Salamonsen LA, et al. Obesity associated advanced glycation end products within the human uterine cavity adversely impact endometrial function and embryo implantation competence. Hum Reprod. 2018. PMID: 29471449. doi:10.1093/humrep/dey029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。